Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy.
Morgan TM, Boorjian SA, Buyyounouski MK, Chapin BF, Chen DYT, Cheng HH, Chou R, Jacene HA, Kamran SC, Kim SK, Kirkby E, Luckenbaugh AN, Nathanson BJ, Nyame YA, Posadas EM, Tran PT, Chen RC. Morgan TM, et al. Among authors: buyyounouski mk. J Urol. 2024 Apr;211(4):518-525. doi: 10.1097/JU.0000000000003891. Epub 2024 Feb 29. J Urol. 2024. PMID: 38421243
Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial.
Mitin T, Hunt D, Shipley WU, Kaufman DS, Uzzo R, Wu CL, Buyyounouski MK, Sandler H, Zietman AL. Mitin T, et al. Among authors: buyyounouski mk. Lancet Oncol. 2013 Aug;14(9):863-72. doi: 10.1016/S1470-2045(13)70255-9. Epub 2013 Jul 1. Lancet Oncol. 2013. PMID: 23823157 Free PMC article. Clinical Trial.
Prostate cancer risk assessment program: a 10-year update of cancer detection.
Giri VN, Beebe-Dimmer J, Buyyounouski M, Konski A, Feigenberg SJ, Uzzo RG, Hanks G, Godwin AK, Chen DY, Gordon R, Cescon T, Raysor S, Watkins-Bruner D. Giri VN, et al. J Urol. 2007 Nov;178(5):1920-4; discussion 1924. doi: 10.1016/j.juro.2007.07.010. Epub 2007 Sep 17. J Urol. 2007. PMID: 17868726
A comparison of acute and chronic toxicity for men with low-risk prostate cancer treated with intensity-modulated radiation therapy or (125)I permanent implant.
Eade TN, Horwitz EM, Ruth K, Buyyounouski MK, D'Ambrosio DJ, Feigenberg SJ, Chen DY, Pollack A. Eade TN, et al. Among authors: buyyounouski mk. Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):338-45. doi: 10.1016/j.ijrobp.2007.10.019. Epub 2008 Jan 22. Int J Radiat Oncol Biol Phys. 2008. PMID: 18207665 Free PMC article.
Does treatment duration affect outcome after radiotherapy for prostate cancer?
D'Ambrosio DJ, Li T, Horwitz EM, Chen DY, Pollack A, Buyyounouski MK. D'Ambrosio DJ, et al. Among authors: buyyounouski mk. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1402-7. doi: 10.1016/j.ijrobp.2008.03.011. Epub 2008 May 9. Int J Radiat Oncol Biol Phys. 2008. PMID: 18472368 Free PMC article.
131 results